Nov 14th, 2021
Monday's Late-Breaking Science presentations

8-9 a.m. EST
LBS.06 | Fish Oil and Cholesterol: Recipes for CVD Prevention?
- Icosapent Ethyl Versus Placebo in Outpatients With COVID-19: The Main Results of PREPARE-IT 2 (PREPARE-IT 2)
- The Clinical Safety, Pharmacokinetics, and LDL-Cholesterol Lowering Efficacy of MK-0616, an Oral PCSK9 Inhibitor
11 a.m.-Noon EST
LBS.07 | New Drugs and New Drug Indications in Cardiovascular Disease
- Effects Of Aspirin on Dementia and Cognitive Impairment in the ASCEND Trial (ASCEND)
- P2y12 Inhibitors in Noncritically Ill Hospitalized Patients With COVID-19 (ACTIV-4A)
- Effect Of Bentracimab on Platelet Inhibition and Hemostasis in Ticagrelor Patients With Uncontrolled Hemorrhage or Requiring Urgent Surgery in the REVERSE-IT (REVERSE-IT)
- Milvexian for Prevention of Venous Thromboembolism After Elective Knee Arthroplasty: The AXIOMATIC-TKR Study (AXIOMATIC-TKR)